Skip to Main Content

Trevor Jeffrey Bush

About

Biography

Trevor Bush is a PhD student in the Pharmacology Department co-mentored by professors Yung-Chi Cheng and Jason Cai. He received his BSc in Biotechnology and Biochemistry at Worcester Polytechnic Institute where he assessed the anti-infective (tuberculosis) and anti-fibrotic capabilities of Artemisia sp. and artemisinic compounds in vitro. He also developed plant-based decellularized scaffolds for modeling disease in 3D.

Now at Yale, he leverages herbal medicine as a multi-target systems pharmacology approach to treat age-related and chronic inflammatory diseases, including neurodegeneration and inflammatory bowel disease.

Last Updated on June 28, 2026.

Education & Training

BSc
Worcester Polytechnic Institute, Biotechnology and Biochemistry

Research

It is time for us as a culture to walk in the forest again. Once we see nature as a mentor, our relationship with the living world changes.

Janine Benyus

Overview

Chronic inflammatory diseases, such as neurodegeneration and gastrointestinal diseases, are multifactorial in their pathology, driven by many interconnected pathways. Western medicine traditionally focuses on a "one-target, one-drug" model. When you block a single target in such a multifaceted pathology, the body often adapts by utilizing compensatory pathways, resulting in a weakened response to treatment and potentially toxic adverse effects.

Trevor is interested in breaking from this reductionist model by investigating how traditional medicinal herbs from across the world can be applied to treat chronic inflammatory diseases through a polychemical, multi-target (polypharmacological), systems approach.

Another interest includes investigating the understudied dysregulation of complex lipid metabolism in disease for diagnostic and prognostic purposes and the impact of medicinal herb interventions on this dysregulation.

Through his efforts, he hopes to further Professor Yung-Chi Cheng's vision of merging Western and Eastern approaches into “WE Medicine.”

Approaches & Techniques:

  • Plant sourcing and preparation
  • Bioactivity guided fractionation
  • Protein-Ligand Kinetics
  • Interaction metabolomics
  • Reporter cell lines
  • Inducible cell models
  • Cellular Thermal Shift Assay (CETSA-MS)
  • Hydrogen Deuterium Exchange (HDX-MS)
  • Molecular docking and dynamics
  • Mouse models
  • Mass spectrometry spatial omics (Proteomics, Lipidomics, Metabolomics)
  • Positron Emission Tomography



Medical Research Interests

Alzheimer Disease; Cardiovascular Diseases; Complex Mixtures; Drug Discovery; Ethnobotany; Ethnopharmacology; Gastrointestinal Diseases; Gastrointestinal Microbiome; Lipidomics; Mass Spectrometry; Medicine, Traditional; Multiomics; Network Pharmacology; Neurodegenerative Diseases; Pharmacology; Plant Extracts; Polypharmacology; Positron-Emission Tomography; Proteomics; Quantitative Structure-Activity Relationship; Systems Biology

Public Health Interests

Aging; Bioinformatics; Biomarkers; Cardiovascular Diseases; Chronic Diseases; Metabolism; Nutrition; Microbiome; Metabolomics; Non-Communicable Diseases; Network Analysis

Get In Touch

Contacts

Locations

  • Cheng Lab

    Lab

    Sterling Hall of Medicine

    333 Cedar Street, Wing B, Fl 2

    New Haven, CT 06510